NTAGI analyzes data of Covid-19 breakthrough infections in India to decide on booster dose

NEW DELHI: To make a decision regarding a

booster dose

of the

Covid-19

vaccine, the National Technical Advisory Group on Immunisation (

NTAGI

) is analyzing data of Covid-19 breakthrough infections in India, said sources on Tuesday.

As per the sources, "NTAGI is analyzing data of Covid-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."

During its last meeting, the NTAGI had made no final recommendation on additional Covid-19

vaccine doses

and vaccines for children. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting.